Sidra Medicine, Rasmal Ventures team-up to drive digital health innovation in Qatar

Rasmal Ventures 9 Mar, 2025 12:00 AM

Sidra Medicine and Rasmal Ventures Partner to Drive Digital Health Innovation in Qatar

Advancing Healthcare Through E-health Innovation and Startup Integration

25 February 2025, Doha, Qatar - Sidra Medicine, a member of Qatar Foundation, has signed a Memorandum of Understanding (MOU) with Rasmal Ventures, Qatar’s first venture capital firm. The strategic partnership, announced at the Web Summit Qatar 2025, marks a significant step in the hospital’s role in supporting and advancing digital health innovation in Qatar and beyond.

Rasmal Ventures, with its extensive portfolio of global technology companies, will introduce Sidra Medicine to high-potential e-health startups and provide strategic support to incorporate innovative solutions into Sidra Medicine’s operations. In return, Sidra Medicine will contribute its clinical and research expertise to evaluate and refine the startups’ healthcare technologies, ensuring they are effective, scalable, and patient-focused. Moreover, the two organizations will develop entrepreneurship programs that encourage the development and growth of a Health-Tech sector for Qatar.

Prof. Khalid Fakhro, Chief Research Officer at Sidra Medicine said: “This partnership highlights our commitment to establishing Sidra Medicine as a leading healthcare innovation hub in Qatar, in alignment with the Qatar National Vision 2030. By collaborating with Rasmal Ventures, we are building upon our current strengths in clinical care, genomics and cell and gene therapy, and taking a proactive approach to adopting innovative technologies and transforming Sidra Medicine into a living lab for entrepreneurial ventures from across Qatar and the world.”

The MOU establishes a collaborative framework between the two entities to facilitate the exchange of expertise and best practices in e-health innovations. Through this partnership, Sidra Medicine and Rasmal Ventures aim to drive advancements in innovation, focusing on digital healthcare solutions such as patient-centric artificial intelligence (AI) technologies, telemedicine platforms, and wearable devices.

Alexander Wiedmer, Co-Managing Partner at Rasmal Ventures said: “At Rasmal Ventures, we believe that innovation is key to transforming healthcare. Our partnership with Sidra Medicine represents a unique opportunity to bring the latest digital health technologies to the forefront, empowering Qatar’s healthcare system to deliver smarter, more efficient, and patient-centered care.”

As part of the agreement, the two entities will host joint workshops, pilot studies, and discussions to validate the efficacy of emerging technologies and foster an open environment for innovation.

This partnership positions Sidra Medicine as a driving force in healthcare innovation, creating valuable opportunities for biotech and healthtech leaders. It also underscores Sidra Medicine’s role as a premier destination for medical education and research, attracting innovators and nurturing the development of next-generation healthcare solutions.

-Ends-

 

About Sidra Medicine

Innovating Care. Transforming Lives

From the heart of Qatar, Sidra Medicine, is a private, not-for-profit academic healthcare and research institution for women, children, and young people.

Established by the Qatar Foundation for Education, Science, and Community Development, Sidra Medicine is committed to delivering exceptional patient and family-focused care, conducting innovative biomedical and clinical research, and providing a personalized journey of care and cure and precision medicine specifically for rare and genetic diseases.

To access our specialized healthcare or international patient services, including pediatric care, women's health, and rare disease treatment or to book a consultation at one of our private clinics, please call +974 40033333 or visit our website at http://www.sidra.org.

For more information, follow us on Facebook, Instagram, X and LinkedIn

 

About Rasmal Ventures

Rasmal Ventures is Qatar’s first independent venture capital fund, with a regional presence across the MENA region. The firm invests in high-potential technology startups and supports top entrepreneurs, including international companies expanding into the MENA market.

Focused primarily on Series A and Series B stage startups, Rasmal Ventures also selectively invests in Pre-Series A and later-stage ventures. While sector-agnostic, the firm has particular expertise in healthtech, fintech, B2B SaaS, supply chain logistics, and Artificial Intelligence (AI). Rasmal Ventures thrives on embracing the fast pace of technological evolution and is committed to learning and exploring new sectors alongside visionary entrepreneurs.

For more information, visit our website at https://www.rasmalventures.com/en